Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 164   

Articles published

NVS 83.51 +0.77 (0.93%)
price chart
Novartis AG (ADR) (NYSE:NVS): Reviewing Earnings Estimates
Novartis AG (ADR) (NYSE:NVS) soared 0.51% or +0.42 points during previous trade after opening at the price of $81.92, a total of 1.58M shares exchanged hands compared with its average trading volume of 1.71M shares.
Novartis AG (ADR) 2Q Earnings: Here's What To Expect?  Bidness ETC
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Novartis AG (ADR) (NYSE:NVS) Biosimilars Roadmap
Novartis AG (ADR) (NYSE:NVS) is in the process of tripling its portfolio of biosimilar drugs by 2020. The company is particularly working to develop alternatives to blockbuster drugs such as Johnson & Johnson (NYSE:JNJ) Remicade and Amgen, Inc.
Novartis AG (ADR) Has Enough Arsenal to Steer Clear of Ongoing Rout  Bidness ETC
How Novartis AG (NYSE:NVS) trades after earning announcements?  Zergwatch
How Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce?
A fresh analysis of Novartis AG (ADR) (NYSE:NVS) drug Entresto has shown that it can significantly reduce heart failure deaths.
Will Novartis AG (ADR) Go Down Anytime Soon?
The stock of Novartis AG (ADR) (NYSE:NVS) is a huge mover today! About 398,721 shares traded hands. Novartis AG (ADR) (NYSE:NVS) has declined 2.98% since December 15, 2015 and is downtrending. It has underperformed by 8.94% the S&P500.
Is Major Move Coming For Novartis AG (ADR) After This Gap Up?  Press Telegraph
Xencor Inc (NASDAQ:XNCR) to Collaborate with Pharma Giant Novartis AG (ADR ...
Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product ...
Benzinga's Volume Movers  Benzinga
Novartis AG (ADR) (NYSE:NVS) Sells 14 Drug Brands Worth $293 Million To Sun In ...
Novartis AG (ADR) (NYSE:NVS) has sold more than a dozen drugs to India's Sun Pharmaceutical in Japan. The development follows a trend that has become popular among major pharmaceutical companies.
Hedge Funds Aren't Crazy About Novartis AG (ADR) (NVS) Anymore
We can judge whether Novartis AG (ADR) (NYSE:NVS) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Will Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) And Novartis AG (ADR ...
It is not clear whether Teva's Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Novartis AG (ADR)(NYSE:NVS) are trying to fend off copy cats.
Bimagrumab (BYM338) drug from Novartis AG (ADR) (NYSE:NVS) Failed a Phase IIb ...
Bimagrumab (BYM338) from Novartis AG (ADR) (NYSE:NVS) failed a Phase IIb/III study. The news of the failure of the study pertaining to a rare, muscle-wasting disease known as sporadic inclusion body myositis was heartbreaking for the pharma giant since ...